The Heart Was Never Refusing to Repair

Cardiac medicine has spent decades asking how to convince a silent organ to regrow. A Circulation Research paper from a University of Sydney team led by Dr. Robert Hume, working with the Baird Institute and Royal Prince Alfred Hospital, redraws the obstacle: the heart is not refusing to repair, it is already trying, and the next task is amplification, not induction.

The instinct after a finding like this is to read it as a cure waiting in the wings. The reframe the authors offer is sharper. They describe the natural mitotic response as too small to replace the cells a heart attack removes, and they describe the next step as therapies that boost the heart's intrinsic response. That is the entire research program in two sentences. The bottleneck is the per-cell division rate and the duration of the mitotic window, not whether cardiomyocytes can divide at all.

The paper's loss ceiling is the load-bearing number: myocardial infarction can eliminate up to a third of the heart's muscle cells. The handful the organ manages to replace on its own does not close that gap, which is why scar tissue remains the default outcome. Once the gap is named, every candidate therapy becomes a question of dosing, timing, and persistence on a process the heart already runs.

The field's center of gravity has shifted. Permission was the wrong question, and supply is the right one.